Hepatic heme and drug metabolism in rats with chronic mountain sickness.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 3094379)

Published in Am J Physiol on October 01, 1986

Authors

H L Bonkovsky, B Lincoln, J F Healey, L C Ou, P R Sinclair, U Muller-Eberhard

Articles by these authors

A gene cluster involved in the utilization of both free heme and heme:hemopexin by Haemophilus influenzae type b. J Bacteriol (1995) 2.08

Branched electron-transport systems in bacteria. Adv Microb Physiol (1971) 1.90

High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology (1995) 1.88

A functional tonB gene is required for both utilization of heme and virulence expression by Haemophilus influenzae type b. Infect Immun (1994) 1.81

Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. Blood (1968) 1.81

Identification of a genetic locus of Haemophilus influenzae type b necessary for the binding and utilization of heme bound to human hemopexin. Proc Natl Acad Sci U S A (1992) 1.80

Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest (1991) 1.77

Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. J Cell Physiol (1988) 1.76

Electron transport system of the protoheme-requiring anaerobe Bacteroides melaninogenicus. J Bacteriol (1968) 1.76

Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. Am J Clin Pathol (1995) 1.68

Pathogenesis of high-altitude pulmonary oedema: direct evidence of stress failure of pulmonary capillaries. Eur Respir J (1995) 1.59

Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity. J Hepatol (2001) 1.56

Serum proteomic profiling in patients with drug-induced liver injury. Aliment Pharmacol Ther (2012) 1.55

Expression of factor VIII by murine liver sinusoidal endothelial cells. J Biol Chem (1999) 1.54

Cytochrome P450 of small intestinal epithelial cells. Immunochemical characterization of the increase in cytochrome P450 caused by phenobarbital. Gastroenterology (1985) 1.47

Heme oxygenase: recent advances in understanding its regulation and role. Proc Assoc Am Physicians (1999) 1.46

Hemopexin. N Engl J Med (1970) 1.46

Resolution of two forms of cytochrome P-450 from liver microsomes of rabbit treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem (1977) 1.41

Inflammatory cloacogenic polyp: three cases and literature review. Am J Gastroenterol (1994) 1.38

Hormonal requirements for the induction of cytochrome P-450 in hepatocytes cultured in a serum-free medium. Biochem Biophys Res Commun (1979) 1.38

Effect of nitrate, fumarate, and oxygen on the formation of the membrane-bound electron transport system of Haemophilus parainfluenzae. J Bacteriol (1970) 1.38

The biosynthesis of the subtilisin-related proprotein convertase PC3, but no that of the PC2 convertase, is regulated by glucose in parallel to proinsulin biosynthesis in rat pancreatic islets. J Biol Chem (1993) 1.36

Partial characterization of the heme-binding serum glycoproteins rabbit and human hemopexin. Biochemistry (1971) 1.26

High-performance liquid chromatographic separation and quantitation of tetrapyrroles from biological materials. Anal Biochem (1986) 1.24

Seizure management in acute hepatic porphyria: risks of valproate and clonazepam. Neurology (1980) 1.23

Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol. Biochem J (1977) 1.21

Pathophysiology of heme synthesis. Semin Hematol (1988) 1.19

Induction of the heme oxygenase-1 gene by metalloporphyrins. Arch Biochem Biophys (2000) 1.17

Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration. Am J Gastroenterol (2000) 1.16

The influence of heme-binding proteins in heme-catalyzed oxidations. Arch Biochem Biophys (1988) 1.16

Identification of an outer membrane protein involved in utilization of hemoglobin-haptoglobin complexes by nontypeable Haemophilus influenzae. Infect Immun (1996) 1.16

Hepatic subcellular metabolism of heme from heme-hemopexin: incorporation of iron into ferritin. Biochem Biophys Res Commun (1979) 1.16

Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells. Role of mitogen-activated protein kinases. J Biol Chem (1998) 1.13

Assessment of cerebral pO2 by EPR oximetry in rodents: effects of anesthesia, ischemia, and breathing gas. Brain Res (1995) 1.13

Binding of porphyrins to rabbit hemopexin and albumin. J Biol Chem (1973) 1.13

Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda. Lancet (1985) 1.11

Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial. Hepatology (2000) 1.09

Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules. Blood (2000) 1.09

Iron and the liver. Acute and long-term effects of iron-loading on hepatic haem metabolism. Biochem J (1981) 1.08

Hemopexin. Methods Enzymol (1988) 1.07

Conversion of 5-aminolaevulinate into haem by liver homogenates. Comparison of rat and chick embryo. Biochem J (1981) 1.06

Preferential cleavage of des-31,32-proinsulin over intact proinsulin by the insulin secretory granule type II endopeptidase. Implication of a favored route for prohormone processing. J Biol Chem (1992) 1.06

Ventilatory response of decorticate and decerebrate cats to hypoxia and CO2. Respir Physiol (1977) 1.06

Fluorimetric study of the binding of protoporphyrin to haemopexin and albumin. Biochem J (1981) 1.06

Plasma hemopexin homeostasis during the acute phase response. J Lab Clin Med (1972) 1.05

Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function. Hepatology (1987) 1.05

Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial. Hepatology (2000) 1.04

A protein of the Z class of liver cytosolic proteins in the rat that preferentially binds heme. J Biol Chem (1985) 1.04

Relationship of the biosynthesis of alpha-fetoprotein, albumin, hemopexin, and haptoglobin to the growth state of fetal rat hepatocyte cultures. Ann N Y Acad Sci (1975) 1.04

Nutritional supplementation in chronic liver disease: an analytical review. Hepatology (1994) 1.03

Identification of rabbit microsomal cytochrome P-450 isozyme, form 1, as a hepatic progesterone 21-hydroxylase. Biochem Biophys Res Commun (1982) 1.03

Iron increases collagenase production by rabbit synovial fibroblasts. J Lab Clin Med (1981) 1.03

Inhibition of uroporphyrinogen decarboxylase by halogenated biphenyls in chick hepatocyte cultures. Essential role for induction of cytochrome P-448. Biochem J (1984) 1.03

Severing of F-actin by the amino-terminal half of gelsolin suggests internal cooperativity in gelsolin. Biophys J (1998) 1.03

Studies on heme transfer from microsomal hemoproteins to heme-binding plasma proteins. Mol Pharmacol (1974) 1.03

Uroporphyrin formation induced by chlorinated hydrocarbons (lindane, polychlorinated biphenyls, tetrachlorodibenzo-p-dioxin). Requirements for endogenous iron, protein synthesis and drug-metabolizing activity. Biochem Biophys Res Commun (1974) 1.02

Factor VIII inhibitors. Adv Exp Med Biol (2001) 1.02

Hepatic heme metabolism and its control. Yale J Biol Med (1979) 1.02

A naturally occurring human/hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell culture. J Gen Virol (2011) 1.01

Non-classical anti-factor VIII C2 domain antibodies are pathogenic in a murine in vivo bleeding model. J Thromb Haemost (2009) 1.01

Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program. J Clin Oncol (1993) 1.00

Ca2+ regulation of gelsolin activity: binding and severing of F-actin. Biophys J (1998) 1.00

Interaction of porphyrins with proteins. Semin Hematol (1977) 1.00

Inefficient recognition of autologous viral sequences by intrahepatic hepatitis C virus-specific cytotoxic T lymphocytes in chronically infected subjects. Virology (1998) 0.99

Iron and the liver: subcellular distribution of iron and decreased microsomal cytochrome P-450 in livers of iron-loaded rats. Arch Pathol Lab Med (1979) 0.99

Decrease in hepatic cytochrome P-450 by cobalt. Evidence for a role of cobalt protoporphyrin. Biochem J (1982) 0.99

Rat hemopexin. Molecular cloning, primary structural characterization, and analysis of gene expression. Biochemistry (1991) 0.99

Expression of 5-aminolaevulinate synthase and cytochrome P-450 mRNAs in chicken embryo hepatocytes in vivo and in culture. Effect of porphyrinogenic drugs and haem. Biochem J (1988) 0.98

Decreased activity of uroporphyrinogen decarboxylase caused by 2,4,5,3',4'-pentabromobiphenyl in chick embryo hepatocyte cultures. Difference in activity in intact or homogenized cells. FEBS Lett (1983) 0.98

Sites of formation of the serum proteins transferrin and hemopexin. J Clin Invest (1973) 0.98

Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C. Hepatology (1998) 0.98

Kinetics of the interaction of hemin liposomes with heme binding proteins. Biochemistry (1984) 0.98

Biosynthesis of the farnesyl moiety of heme a from exogenous mevalonic acid by cultured chick liver cells. Arch Biochem Biophys (1986) 0.97

Quantitative determination of hemoglobin and cytochemical staining for peroxidase using 3,3',5,5'-tetramethylbenzidine dihydrochloride, a safe substitute for benzidine. Anal Biochem (1979) 0.97

Synthesis of hemopexin and cysteine protease inhibitor is coordinately regulated by HSF-II and interferon-beta 2 in rat hepatoma cells. Biochem Biophys Res Commun (1987) 0.97

Purification, characterization, and cloning of a heme-binding protein (23 kDa) in rat liver cytosol. Biochemistry (1995) 0.97

Tissue localization of the heme-hemopexin complex in the rabbit and the rat as studied by light microscopy with the use of radioisotopes. J Lab Clin Med (1970) 0.94

The aromatic and heme chromophores of rabbit hemopexin. Difference absorption and fluorescence spectra. Biochim Biophys Acta (1976) 0.94

Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools. Am J Gastroenterol (1991) 0.94

Protection of the Cyp1a2(-/-) null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol (2001) 0.94

Identification of the major cytochrome P-450 form transplacentally induced in neonatal rabbits by 3,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem (1978) 0.94

Interactions of porphyrins with rabbit hemopexin. J Biol Chem (1972) 0.94

Advances in understanding and treating 'the little imitator,' acute porphyria. Gastroenterology (1993) 0.94

Heme regulates hepatic 5-aminolevulinate synthase mRNA expression by decreasing mRNA half-life and not by altering its rate of transcription. Arch Biochem Biophys (1991) 0.93

Human and rabbit hemopexins: tryptic peptides and N-terminal sequences. FEBS Lett (1974) 0.93

Heme control on the synthesis of delta-aminolevulinic acid synthetase in cultured chick embryo liver cells. Ann N Y Acad Sci (1975) 0.93

Secretion of haem by hepatic parenchymal cells. Biochem J (1979) 0.93

Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease. Drugs (1990) 0.93

Mixed cryoglobulinemia in chronic hepatitis C infection. A clinicopathologic analysis of 10 cases and review of recent literature. Medicine (Baltimore) (1994) 0.93

Regulation of hepatic haem metabolism. Disparate mechanisms of induction of haem oxygenase by drugs and metals. Biochem J (1988) 0.92

The rat and human hemopexin genes contain an identical interleukin-6 response element that is not a target of CAAT enhancer-binding protein isoforms. J Biol Chem (1994) 0.92

The porphyrias. Dis Mon (1989) 0.92